Poor response to erlotinib in patients with tumors containing baseline EGFR T790M mutations found by routine clinical molecular testing

Por Yu, H. A., Arcila, M. E., Hellmann, M. D., Kris, M. G., Ladanyi, M., Riely, G. J.
Publicado em 2014

Targeting HER2 aberrations as actionable drivers in lung cancers: phase II trial of the pan-HER tyrosine kinase inhibitor dacomitinib in patients with HER2-mutant or amplified tumo...

Por Kris, M. G., Camidge, D. R., Giaccone, G., Hida, T., Li, B. T., O'Connell, J., Taylor, I., Zhang, H., Arcila, M. E., Goldberg, Z., Jänne, P. A.
Publicado no Ann Oncol (2015)

Clinical Characteristics and Course of 63 patients with BRAF Mutant Lung Cancers

Por Litvak, A.M., Paik, P.K., Woo, K. M., Sima, C. S., Hellmann, M. D., Arcila, M.E., Ladanyi, M., Rudin, C. M., Kris, M. G., Riely, G. J.
Publicado no J Thorac Oncol (2014)

Cancer-testis antigen expression and immunogenicity in AL amyloidosis

Por Rosenzweig, M A, Landau, H, Seldin, D, O'Hara, C, Girnius, S, Hanson, N, Frosina, D, Sedrak, C, Arcila, M, Comenzo, R L, Giralt, S, Gnjatic, S, Jungbluth, A A, Koehne, G
Publicado em 2012

Clonal B cells in Waldenström's macroglobulinemia exhibit functional features of chronic active B-cell receptor signaling

Por Argyropoulos, K V, Vogel, R, Ziegler, C, Altan-Bonnet, G, Velardi, E, Calafiore, M, Dogan, A, Arcila, M, Patel, M, Knapp, K, Mallek, C, Hunter, Z R, Treon, S P, van den Brink, M R M, Palomba, M L
Publicado no Leukemia (2016)

Genomic Alterations and Outcomes with VEGF-Targeted Therapy in Patients with Clear Cell Renal Cell Carcinoma

Por Carlo, M.I., Manley, B., Patil, S., Woo, K.M., Coskey, D.T., Redzematovic, A., Arcila, M., Ladanyi, M., Lee, W., Chen, Y.B., Lee, C.H., Feldman, D.R., Hakimi, A.A., Motzer, R.J., Hsieh, J.J., Voss, M.H.
Publicado no Kidney Cancer (2017)

Whole-genome sequencing suggests a chemokine gene cluster that modifies age at onset in familial Alzheimer's disease

Por Lalli, M A, Bettcher, B M, Arcila, M L, Garcia, G, Guzman, C, Madrigal, L, Ramirez, L, Acosta-Uribe, J, Baena, A, Wojta, K J, Coppola, G, Fitch, R, de Both, M D, Huentelman, M J, Reiman, E M, Brunkow, M E, Glusman, G, Roach, J C, Kao, A W, Lopera, F, Kosik, K S
Publicado no Mol Psychiatry (2015)

What hides behind the MASC: clinical response and acquired resistance to entrectinib after ETV6-NTRK3 identification in a mammary analogue secretory carcinoma (MASC)

Por Drilon, A., Li, G., Dogan, S., Gounder, M., Shen, R., Arcila, M., Wang, L., Hyman, D. M., Hechtman, J., Wei, G., Cam, N. R., Christiansen, J., Luo, D., Maneval, E. C., Bauer, T., Patel, M., Liu, S. V., Ou, S. H. I., Farago, A., Shaw, A., Shoemaker, R. F., Lim, J., Hornby, Z., Multani, P., Ladanyi, M., Berger, M., Katabi, N., Ghossein, R., Ho, A. L.
Publicado no Ann Oncol (2016)